but by innovation capability.
This report analyzes the structural shift in the global pharmaceutical industry from scale-driven growth to innovation-driven competitiveness.
It focuses on how leading companies are redefining performance through R&D productivity, pipeline quality, and therapeutic concentration.
The analysis is designed to inform strategic planning, investment decisions, and business development across the pharmaceutical industry.
A. Transformation of Competitive Structure
Company Rankings
Market Capitalization and Growth Profiles
Growth Map
Financial Analysis
Industry Evolution (M&A Trends)
B. Trends in the New Drug Market
Top 50 Products by 2025 Sales
Market Concentration of New Drugs
Product Rankings (Top 1–300)
R&D Scorecard: 2025
R&D Pipeline : Tier Analysis (by Revenue and Market Cap)
The full report extends this analysis with:
Comparative analysis of top 15 pharmaceutical companies
Quantitative benchmarking of R&D productivity and pipeline quality and depth
Product-level growth structure and sustainability assessment
Identification of structural shifts in industry competition
Access the full analysis and comprehensive data in the eBook edition.
> Sections